Thursday, February 16, 2012

Sjogren's Syndrome Update

Bonnie: Based upon the results presented at the last meeting of the American College of Rheumatology in November 2011, there is not much to update that is positive. Most drug therapies have shown to be ineffective. The one drug that has shown promise, Rituxan, is used off-label. Rituxan is approved for non-hodgkin's lymphoma and the side effects are monstrously horrific.

From a nutritional standpoint, discovering food intolerances are paramount for managing Sjogren's. Just as important is to evaluate vitamin D level and supplement accordingly if low (which is usually the case) with vitamin D3. Optimal levels of vitamin A and B-6 have also been shown to be important for Sjogren's sufferers.

No comments:

Post a Comment